Summary
Since his childhood a now 31-year-old male showed typical symptoms of parathyroid hormone deficiency with hypocalcemia and hyperphosphatemia.
We found a target organ resistance to parathyroid hormone and diagnosed pseudohypoparathyroidism. In addition adrenal insufficiency with hypocortisolism was seen. Both hormone systems act by stimulating adenylate cyclase. A defective receptor-adenylate cyclase complex may cause this — for the first time described — combination of endocrine insufficiency.
Similar content being viewed by others
Abbreviations
- AHO:
-
Albright's Hereditary Osteodystrophy
- PHP:
-
Pseudohypoparathyreoidismus
- hPTH:
-
humanes Parathormon
- cAMP:
-
cyclisches Adenosinmonophosphat
- GTP:
-
Guanosintriphosphat
- ACTH:
-
Adrenocorticotropes Hormon
- LH-RH:
-
Luteinisierendes Hormon — Releasing-Hormon
- TRH:
-
Thyreotropin-Releasing-Hormon
- CRH:
-
Corticotropin-Releasing-Hormon
Literatur
Albright F, Burnett CH, Smith PH, Parsons W (1942) Pseudohypoparathyroidism — an example of „Seabright-Bantam Syndrome“. Report of three cases. Endocrinology 30:922–932
Bell HN, Avery S, Sinha T, Clark LC Jr, Allen DO, Johnston C Jr (1976) Effects of dibutyryl cyclic adenosine 3′5′-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. J Clin Invest 51:816–832
Bourne HR, Kaslow HR, Brickmann AS, Farfel Z (1981) Fibroblast defect in pseudohypoparathyroidism, type I:reduced activity of receptor-cyclase coupling protein. J Clin Endocrinol Metab 53:634–640
Brickmann AS, Carlson HE, Seymour RL (1986) Responses to glucagon infusion in pseudohypoparathyroidism. J Clin Endocrinol Metab 63:1354–1360
Carlson HE, Brickmann AS, Bottazo GF (1977) Prolactin deficiency in pseudohypoparathyroidism. New Eng J Med 296:140–144
Chase LR, Aurbach GD (1967) Parathyroid function and the renal excretion of 3′5′-Adenylic acid. Proceedings of the National Academy of Science of the USA 58:518–525
Chase LR, Melson GL, Aurbach GD (1969) Pseudohypoparathyroidism: defective excretion of 3′, 5′,-AMP in response to parathyroid hormone. J Clin Invest 48:1822–1844
Downs RW, Sekura RD, Levine MA, Spiegel AO (1983) Deficient adenylat cyclase regulating proteins in renal membranes from a patient with pseudohypoparathyroidism. J Clin Invest 71:231–235
Drezner MK, Burch WM Jr (1978) Altered activity of the nucleotide regulatory site in the parathyroid hormone sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J Clin Invest 62:1222–1227
Drezner M, Neelon FA, Lebovitz HE (1973) Pseudohypoparathyroidism Type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med 289:1056–1060
Farfel Z, Bourne HR (1980) Deficient activity of receptor-cyclase coupling protein in platelets of patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 51:1202–1204
Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Bourne HR (1980) Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N Engl J Med 303:237–242
Farfel Z, Friedman E (1986) Mental Deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency. Ann Int Med 105:197–199
Fischer JA, Bourne HR, Dambacher MA, Tschopp F, de Meyer R, Devogelaer JP, Werder EA, Nagant de Deuxchaisnes C (1983) Pseudohypoparathyroidism: inheritance and expression of deficient receptor cyclase coupling protein activity. Clin Endocrinol (Oxford) 19:747–754
Gilman AG (1984) Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J Clin Invest 73:1–4
Helmreich EJM (1986) Fortschritte der molekularen Endokrinologie. Klin Wochenschr 64:669–681
Kruse K (1982) Durch Rezeptordefekte verursachte angeborene Endokrinopathien. Klin Pädiatr 194:359–374
Kruse K (1988) Hypoparathyreoidismus und Pseudohypoparathyreoidismus. Neue Aspekte in der Pathogenese, Diagnose und Therapie. Monatsschr Kinderheilkd 136:652–666
Kruse K, Gutekunst B, Kracht U, Schwerda K (1981) Deficient prolactin response to parathyroid hormone in hypocalcemic and normocalcemic pseudohypoparathyroidism. J Clin Endocrinol Metab 52:1099–1105
Kruse K, Kracht U (1987) A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1–38 fragment of human parathyroid hormone. Eur J Pediatr 146:373–377
Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556
Levine MA, Downs RW, Singer M, Marx SJ, Aurbach GD, Spiegel AM (1980) Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 94:1319–1324
Mallet E, Carayon P, Aniv S, Brunelle P, Ducastelle T, Banyan JP, DeMenibus CH (1982) Coupling defect of thyrotropin receptor and adenylate cyclase in pseudohypoparathyroid patient. J Clin Endocrinol 54:1028–1032
Marx SJ, Hershman JM, Aurbach GD (1971) Thyroid dys-function in pseudohypoparathyroidism. J Clin Endocrinol Metab 33:822–828
Moses AM, Breslau N, Coulson R (1972) Renal responses to PTH in patients with hormone-resistant (pseudo) hypoparathyroidism. Am J Med 61:184–189
Nagant De Deuxchaisnes C, Fischer JA, Dambacher MA, Devogelaer JP, Arber CE, Zanelli JM, Parsons JA, Loveridge N, Bitensky J, Chayen J (1981) Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I. Endocrinol Metab 53:1105–1109
Radeke HH, Auf'm Kolk B, Jüppner H, Krohn HP, Keck E, Hesch RD (1986) Multiple pre- and postreceptor defects in pseudo-hypoparathyroidism (a multicenter study with twenty four patients). J Endocrinol Metab 62:393–402
Silve C, Santova A, Breslau N, Moses A, Spiegel AM (1986) Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 62:640–644
Steinbach HL, Young DA (1966) The Roentgen appearance of pseudohypoparathyroidism (PH) and pseudopseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals, and phalanges. Am J Roentgenol Ther Nucl Med 97:49–66
Tashjian AH Jr, Frantz AG, Lee JB (1966) Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci USA 56:1138–1142
Werder EA (1979) Pseudohypoparathyroidism. Ergeb Inn Med Kinderheilkd 42:191–221
Wolfsdorf JI, Rosenfield RL, Fang VS, Koberyashi R, Razdan AK, Moon H (1978) Partial gonadotropin-resistance in pseudohypoparathyroidism. Acta endocrinologica 88:321–328
Yamamoto M, Takuwa Y, Masuko S, Ogata E (1988) Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism. Endocrinol Metab 66:618–625
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ridderskamp, P., Schlaghecke, R. Pseudohypoparathyreoidismus und Nebennierenrindeninsuffizienz. Klin Wochenschr 68, 927–931 (1990). https://doi.org/10.1007/BF01649041
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649041